^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    obrindatamab (MGD009)

    i
    Other names: MGD009
    Associations
    News
    Trials
    Company:
    MacroGenics
    Drug class:
    CD3 agonist, B7-H3 inhibitor
    Related drugs:
    Associations
    News
    Trials